BI 655066
Showing 1 - 25 of 1,415
Psoriasis Trial in Russian Federation (risankizumab, for rizankizumab)
Completed
- Psoriasis
- risankizumab
- placebo for rizankizumab
-
Krasnodar, Krasnodarskiy Kray, Russian Federation
- +5 more
Jan 22, 2021
Crohn Disease Trial in Worldwide (Risankizumab 600 mg IV, Risankizumab 180 mg SC)
Completed
- Crohn Disease
- Risankizumab 600 mg IV
- Risankizumab 180 mg SC
-
Chevy Chase, Maryland
- +27 more
Apr 9, 2020
Psoriasis Trial (risankizumab, for risankizumab)
Arthritis, Psoriatic Trial (risankizumab, for risankizumab)
Completed
- Arthritis, Psoriatic
- risankizumab
- placebo for risankizumab
- (no location specified)
May 28, 2019
Ankylosing Spondylitis (AS) Trial ( for risankizumab, risankizumab)
Completed
- Ankylosing Spondylitis (AS)
- placebo for risankizumab
- risankizumab
- (no location specified)
May 30, 2019
Psoriasis Trial in Puerto Rico, United States (Risankizumab, Placebo solution for risankizumab)
Completed
- Psoriasis
- Risankizumab
- Placebo solution for risankizumab
-
Birmingham, Alabama
- +42 more
Feb 19, 2021
Psoriasis Trial in New York (Risankizumab-Rzaa, Punch biopsies of the skin at baseline visit, Punch biopsies of the skin at week
Recruiting
- Psoriasis
- Risankizumab-Rzaa
- +2 more
-
New York, New YorkThe Rockefeller Univesity
Jun 9, 2022
Psoriasis Trial in Germany (Fumaderm, risankizumab)
Completed
- Psoriasis
-
Heidelberg, Baden-Wuerttemberg, Germany
- +22 more
Aug 7, 2019
Ulcerative Colitis (UC) Trial in Worldwide (risankizumab IV, for risankizumab, risankizumab SC)
Recruiting
- Ulcerative Colitis (UC)
- risankizumab IV
- +2 more
-
Coronado, California
- +429 more
Aug 11, 2022
Psoriatic Arthritis (PsA) Trial in Worldwide (Placebo, Risankizumab)
Active, not recruiting
- Psoriatic Arthritis (PsA)
- Placebo
- Risankizumab
-
Anniston, Alabama
- +137 more
Feb 28, 2022
Psoriasis Trial in Worldwide (risankizumab)
Active, not recruiting
- Psoriasis
- risankizumab
-
Birmingham, Alabama
- +232 more
Nov 4, 2021